PREDICTING ALL-CAUSE AND PROSTATE CANCER SPECIFIC MORTALITY FOLLOWING DEFINITIVE THERAPY FOR LOCALIZED PROSTATE CANCER

被引：0
|
作者：
Isariyawongse, Brandon
Stephenson, Andrew
Kattan, Michael
Gao, Tianming
Haslag-Minoff, Jennifer
Nepple, Kenneth
Piccirillo, Jay
Ciezki, Jay
Klein, Eric
Kibel, Adam
机构：
来源：
JOURNAL OF UROLOGY | 2012年 / 187卷 / 04期
关键词：
D O I：
10.1016/j.juro.2012.02.212
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
161
引用
收藏
页码：E67 / E67
页数：1
相关论文
共 50 条
  • [21] Factors impacting all-cause mortality in prostate cancer brachytherapy patients with or without androgen deprivation therapy
    Taira, Al V.
    Merrick, Gregory S.
    Galbreath, Robert W.
    Butler, Wayne M.
    Wallner, Kent E.
    BRACHYTHERAPY, 2010, 9 (01) : 42 - 49
  • [22] Determinants of prostate cancer-specific survival following radiation therapy for patients with clinically localized prostate cancer
    D'Amico, AV
    PROSTATE AND RENAL CANCER, BENIGN PROSTATIC HYPERPLASIA, ERECTILE DYSFUNCTION AND BASIC RESEARCH: AND UPDATE, 2003, : 380 - 389
  • [23] Vitamin D Deficiency at Diagnosis Increases All-Cause and Prostate Cancer-specific Mortality in Jamaican Men
    McGrowder, Donovan
    Tulloch-Reid, Marshall K.
    Coard, Kathleen C. M.
    McCaw-Binns, Afette M.
    Ferguson, Trevor S.
    Aiken, William
    Harrison, Leroy
    Anderson, Simon G.
    Jackson, Maria D.
    CANCER CONTROL, 2022, 29
  • [24] PSA Failure as a Surrogate for All-Cause Mortality in Men with Locally Advanced Prostate Cancer
    King, M.
    Chen, M. H.
    D'Amico, A. V.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E857 - E857
  • [25] Fat Intake After Diagnosis and Risk of Lethal Prostate Cancer and All-Cause Mortality
    Richman, Erin L.
    Kenfield, Stacey A.
    Chavarro, Jorge E.
    Stampfer, Meir J.
    Giovannucci, Edward L.
    Willett, Walter C.
    Chan, June M.
    JAMA INTERNAL MEDICINE, 2013, 173 (14) : 1318 - 1326
  • [26] Other and All-Cause Mortality among Men Diagnosed with Prostate Cancer in the PLCO Trial
    Pierre-Victor, Dudith
    Pinsky, Paul F.
    Miller, Eric
    Parnes, Howard
    JOURNAL OF UROLOGY, 2021, 205 (05): : 1372 - 1377
  • [27] The UCSF cancer of the prostate risk assessment (CAPRA) score accurately predicts metastasis, prostate cancer mortality, and all-cause mortality regardless of treatment type
    Cooperberg, Matthew R.
    Broering, Jeannette M.
    Carroll, Peter R.
    JOURNAL OF UROLOGY, 2008, 179 (04): : 114 - 115
  • [28] 15-Year Cause Specific and All-Cause Survival Following Brachytherapy for Prostate Cancer: Negative Impact of Long-Term Hormonal Therapy
    Stone, Nelson N.
    Stock, Richard G.
    JOURNAL OF UROLOGY, 2014, 192 (03): : 754 - 759
  • [29] Prostate cancer risk group is associated with other-cause mortality in men with localized prostate cancer
    Rasul, Rehana
    Golden, Anne
    Feuerstein, Michael A.
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2020, 14 (10): : E507 - E513
  • [30] Review: PSA-based screening does not reduce prostate cancer mortality or all-cause mortality
    Dahm, Philipp
    ANNALS OF INTERNAL MEDICINE, 2012, 156 (08)
12345